Page 2 - Q2 Results

Sobha share rallies 6% as Q2 profit climbs 75% YoY; check details here

The rise in Sobha share price came on the back of stellar show in the September quarter of financial year 2025 (Q2FY25)

Garware Technical hits record high post Q2; board approves bonus issue

The textile product company's board approved a bonus issue of 7,94,12,676 shares of Rs 10 each

Honasa Consumer stock tanks 20%, hits 52-week low on weak Q2 results

Mamaearth is growing slower than expectations and Honasa said the company is making identified structural changes to bring it back to its growth trajectory in a few quarters.

Weak urban demand weighs on FMCG firms in Q2 despite rural market recovery

Urban demand grew by 2.8 per cent, while rural demand increased by 6 per cent, up from 5.2 per cent in the April-June quarter

Starlineups Enterprise Q2FY25 results: PAT jumps over 2-fold to Rs 3.25 cr

Diamonds and jewellery trader Starlineps Enterprise Ltd has reported more than two-fold jump in net profit to Rs 3.25 crore for the July-September quarter of 2024-25 compared to the year-ago period on higher income, according to a statement. The Surat-based company posted more than two-fold rise in revenue to Rs 24.43 crore for the September quarter of FY25 compared to Rs 9.07 crore revenue in the year-ago period, Starlineps Enterprise said in the statement. The Surat-based wholesale and retail trader of diamonds and jewellery also announced a strategic investment in EdTech platform Fusion Klassroom Edutech and acquisition of GenAI-powered platform CUR8. The company recently incorporated a wholly-owned subsidiary, Starlineps International Pvt Ltd.

MFIs, OMCs top Q2 miss list; PSBs, commodities surprise on upside

The study showed almost all microfinance institutions and companies in the oil refining & marketing space have missed estimates

Fusion Finance stays in red with Q2 net loss of Rs 305 cr; GNPA hits 9.4%

Its impairment for financial instruments, that is credit costs, shot up to Rs 694.05 crore in Q2Fy25 from Rs 76.2 crore in Q2FY24 and Rs 348.47 crore in Q1FY25

Happiest Minds Technologies Q2 results: Net profit falls 15% to Rs 49.52 cr

IT firm Happiest Minds Technologies has posted a 15.2 per cent on-year decline in consolidated net profit to Rs 49.52 crore in the September 2024 quarter. It reported a net profit of Rs 58.46 crore in the year-ago period, according to a regulatory filing on Wednesday. Revenue from operations during the quarter under review came in at Rs 521.64 crore, an increase of 28.2 per cent from Rs 406.62 crore in Q2 FY24. Seen quarter-on-quarter, profit dipped 2.9 per cent but revenue rose 12.4 per cent. Terming it as the "best growth results since the last two years", company Executive Chairman Ashok Soota said the transformational changes the company initiated this year are gathering momentum. "These changes include the acquisition of PureSoftware and Aureus, the creation of our GenAI Business Unit (GBS), hiring a senior leader to expand net new (NN Sales), and creating six industry groups, each headed by an industry manager. The full impact of all these changes on revenue and growth will

E.I.D. Parry Q2 results: Net profit declines 24% to Rs 591.66 crore

Sugar manufacturer E.I.D. Parry India Ltd has recorded a consolidated profit after tax for the July-September 2024 quarter at Rs 591.66 crore, the company said. The city-headquartered Murugappa Group company had registered a consolidated profit after tax of Rs 781.85 crore in the corresponding quarter of last financial year. For the six months period ending September 30, 2024, the consolidated profit after tax fell to Rs 817.53 crore from Rs 1,106.75 crore registered year ago. The total income during the quarter under review went up to Rs 9,399.73 crore, from Rs 9,210.31 crore registered in the year ago period. For the half year ending September 30, 2024, the consolidated total income stood at Rs 16,206.71 crore, as against Rs 16,225.58 crore registered during the corresponding period of last financial year. Commenting on the financial performance, company Whole-Time Director and Chief Executive Officer Muthiah Murugappan said, "the standalone profit of sugar segment was lower in

Jaypee Infratech posts Rs 88.2 cr profit in Q2; MD & CEO Aalok Dave resigns

Jaypee Infratech Ltd has reported a consolidated net profit of Rs 88.20 crore for the September quarter. The company had posted a net loss of Rs 588.31 crore in the year-ago period. Total income declined to Rs 222.86 crore in the second quarter of the 2024-25 fiscal year from Rs 357.92 crore in the corresponding period of the previous year, according to a regulatory filing on Thursday. In June this year, the Mumbai-based Suraksha Group took control of the Jaypee Infratech Ltd (JIL) by constituting a three-member board. Sudhir V Valia, promoter of Suraksha Group, was appointed as a non-executive director on the JIL board. The takeover followed the insolvency appellate tribunal NCLAT decision on May 24, 2024, upholding Suraksha Group's bid to acquire JIL. The date of the NCLAT order, May 24, has been treated as the 'Approval Date' as defined in the approved resolution plan. The NCLAT had directed Suraksha Group to pay an additional Rs 1,334 crore to Yamuna Expressway Industrial ...

Lenovo looks to expand as Q2 results beat estimates; eyes AI growth

The Chinese technology company reported revenue of $17.9 billion for the quarter ended Sept 30, exceeding analysts' expectations of $16 billion

Grasim Industries Q2FY25 results: Net profit falls 45.6% to Rs 1,100 crore

Aditya Birla Group flagship holding firm Grasim Industries Ltd on Thursday reported a 45.64 per cent decline in consolidated net profit to Rs 1,100.16 crore for the September quarter, impacted by lower profitability in the cement business and investments in the Building Materials and Renewables businesses. The company had posted a net profit of Rs 2,024.05 crore during the July-September period a year ago, according to a regulatory filing by Grasim Industries -- the holding firm for leading group companies such as UltraTech, Aditya Birla Capital, and Aditya Birla Renewables. Its revenue from operations was up 11.05 per cent to Rs 33,562.85 crore during the quarter under review from Rs 30,220.68 crore a year earlier. The revenue growth was "driven by the superior performance of financial services, cellulosic staple fibre and specialty chemicals businesses", Grasim Industries said in an earning statement. However, consolidated EBITDA declined "as a result of lower profitability in th

Hero MotoCorp Q2 results: Net profit up 5.6% on high rural demand

The consolidated revenue rose to Rs 10,482.93 crore while net profit for the quarter came in at Rs 1,063 crore

Glenmark Pharma Q2 profit rises on strong India business performance

The company also reported a 14.6 per cent rise in revenues in the European market to Rs 687.4 crore, while recording a 1.2 per cent revenue drop in the North America market

EaseMyTrip Q2FY25 results: Net profit declines 45% to Rs 26 crore

The Delhi-headquartered company's gross booking revenue (GBR) from hotels and packages reached Rs 2,414 million, marking a 178.4 per cent Y-o-Y growth

Hero MotoCorp Q2 results: PAT rises 6% to Rs 1,066 crore on higher sales

The country's largest two-wheeler maker had reported a profit after tax (PAT) of Rs 1,007 crore in the July-September quarter of last fiscal

Muthoot Finance Q2 results: Consolidated net profit up 21% at Rs 1,321 cr

Impairment on financial instruments grew sharply to Rs 420 crore in Q2 FY25 from Rs 81.14 crore in Q2 FY24

Glenmark Pharma Q2 results: PAT rises to Rs 354 cr on chronic drugs demand

The drugmaker reported a consolidated profit of Rs 354 crore (nearly $42 million) for the quarter ended Sept. 30, compared with a loss of Rs 81.95 crore a year ago

Ipca Labs Q2 results: PAT rises 58% to Rs 229 cr, revenue at Rs 2,355 cr

Ipca Laboratories on Thursday said its consolidated net profit declined 58 per cent year-on-year to Rs 229 crore in the September quarter. The drug firm had reported a net profit of Rs 145 crore in the year-ago period. Revenue from operations rose to Rs 2,355 crore for the second quarter of the current fiscal year as compared with Rs 2,034 crore in the year-ago period, Ipca Laboratories said in a regulatory filing. The company said its domestic formulations business revenue stood at Rs 940 crore for the quarter, up 11 per cent from Rs 845 crore a year earlier. Export of generics stood at Rs 286 crore in the July-September period as against Rs 264 crore, registering a year-on-year growth of 8 per cent. The company said its board has approved an interim dividend of Rs 21 per share of Re 1 each for 2024-25. Shares of the company on Thursday ended 2.02 per cent up at Rs 1,538.65 apiece on the BSE.

Medanta Hospitals Q2 results: Net profit rises 4.5% to Rs 130 crore

The company's ARPOB per day rose to Rs 62,140 in Q2 FY25, a marginal growth of 1.9 per cent Y-o-Y compared to Rs 61,003 reported for the same period last year